Dr. Ify Mordi is a Consultant Cardiologist at NHS Tayside and a Clinical Senior Lecturer at the University of Dundee, where he focuses on the cardiovascular complications of diabetes and heart failure. He holds a British Heart Foundation Intermediate Clinical Research Fellowship and leads major clinical trials, including studies on SGLT2 inhibitors for patients with type 1 diabetes and heart failure. Dr. Mordi is also at the forefront of AI-driven cardiovascular research, including work showing how routine retinal scans can help predict heart attack and stroke risk. His research aims to bridge clinical care and innovation to improve patient outcomes.